HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.

5th Edition of International Heart Congress

June 24-26, 2027 | Hybrid Event

June 24 -26, 2027 | Rome, Italy

Angiotensin Receptor Blockers

Angiotensin Receptor Blockers

Angiotensin Receptor Blockers (ARBs) play a crucial role in the field of cardiovascular medicine by targeting the renin-angiotensin-aldosterone system. These medications, also known as angiotensin II receptor antagonists, work by blocking the action of angiotensin II on specific receptors, thereby dilating blood vessels and reducing the workload on the heart. ARBs are commonly prescribed to manage conditions such as hypertension, heart failure, and diabetic nephropathy. By modulating the effects of angiotensin II, ARBs contribute to blood pressure regulation and the overall well-being of individuals with cardiovascular concerns. Their distinct mechanism of action and efficacy make ARBs a valuable class of drugs in the therapeutic arsenal against cardiovascular diseases, offering patients a targeted and effective approach to managing their health.

Committee Members
Speaker at International Heart Congress 2027 - Federico Benetti

Federico Benetti

Benetti Foundation, Argentina
Speaker at International Heart Congress 2027 - Mekhman N Mamedov

Mekhman N Mamedov

National Research Center for Preventive Medicine, Russian Federation
Speaker at International Heart Congress 2027 - Syed Raza

Syed Raza

Awali Hospital, Bahrain
Heart Congress 2027 Speakers
Speaker at International Heart Congress 2027 - Federico Benetti

Federico Benetti

Benetti Foundation, Argentina
Speaker at International Heart Congress 2027 - Mekhman N Mamedov

Mekhman N Mamedov

National Research Center for Preventive Medicine, Russian Federation
Speaker at International Heart Congress 2027 - Syed Raza

Syed Raza

Awali Hospital, Bahrain
Speaker at International Heart Congress 2027 - Uwe Peter Tigor

Uwe Peter Tigor

Auxilius Pharma, United States
Tags

Submit your abstract Today

Watsapp